Ceftriaxone Sodium
Ceftriaxone for Injection, USPADD-Vantage Vials
Approved
Approval ID
128bb292-d174-4769-b3e6-9f16617f31e3
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 10, 2024
Manufacturers
FDA
Hospira, Inc
DUNS: 141588017
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Ceftriaxone Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0409-7333
Application NumberANDA065204
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ceftriaxone Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 19, 2018
FDA Product Classification
INGREDIENTS (1)
CEFTRIAXONE SODIUMActive
Quantity: 1 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM
Ceftriaxone Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0409-7336
Application NumberANDA065204
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ceftriaxone Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 19, 2018
FDA Product Classification
INGREDIENTS (1)
CEFTRIAXONE SODIUMActive
Quantity: 2 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM